Identification of New BMP6 Pro-Peptide Mutations in Patients with Unexplained Iron-Overload by Piubelli, C et al.
This is the author's final version of the contribution published as:
Identification of New BMP6 Pro-Peptide Mutations in Patients with Unexplained 
Iron-Overload
Chiara Piubelli, Annalisa Castagna, Giacomo Marchi, Monica Rizzi, Fabiana Busti, 
Monia Marchetti, Marco De Gobbi, Antonella Roetto, Luciano Xumerle, Alejandro 
Giorgetti, Massimo Delledonne, Oliviero Olivieri  and Domenico Girelli. BLOOD. 
Volume: 128. Pages: 264. Published: DEC 2016
The publisher's version is available at:
 [http://www.bloodjournal.org/content/128/22/264]
When citing, please refer to the published version.
Link to this full text: 
[inserire l'handle completa, preceduta da http://hdl.handle.net/]
iris-AperTO
University of Turin’s Institutional Research Information System and Open Access Institutional Repository
Identification of New BMP6 Pro-Peptide Mutations in Patients with Unexplained Iron-
Overload
Chiara Piubelli 1-2, Annalisa Castagna 1-2, Giacomo Marchi 1-2, Monica Rizzi, 1-2 Fabiana 
Busti 1-2, Monia Marchetti 3, Marco De Gobbi 4, Antonella Roetto 5, Luciano Xumerle 6, 
Alejandro Giorgetti 6, Massimo Delledonne 6, Oliviero Olivieri  1-2 and Domenico Girelli
1 Department of Medicine, University of Verona, Verona, Italy 
2 Veneto Region Referral Centre for Iron Disorders, Azienda Ospedaliera Universitaria 
Integrata di Verona, Verona, Italy
3 Oncology Unit, Ospedale Cardinal Massaia, ASTI, Italy
4 Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy
5 Dept. Of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy
6 Department of Biotechnology, University of Verona, Verona, Italy
Background
Hereditary Hemochromatosis (HH) is a genetically heterogeneous disorder caused by 
mutations in at least 5 different genes (HFE, HJV, TFR2, SLC40A1, and HAMP) involved in the 
production and function of the liver hormone hepcidin, a key regulator of iron metabolism. 
Nevertheless, patients with a HH-like phenotype that remains unexplained, despite extensive 
sequencing of the known genes, are not infrequently seen at referral centres, implicating the 
role of still unknown genetic factors. A compelling candidate is Bone Morphogenetic Protein 6 
(BMP6), a member of TGFb superfamily, whose expression is stimulated by increased iron 
stores in the liver. BMP6 acts as a major activator of the BMP-SMAD signalling pathway, 
ultimately leading to the upregulation of hepcidin gene transcription. Indeed, early this year 
French Authors have described 3 heterozygous missense mutations in BMP6 (p.Pro95Ser, 
p.Leu96Pro, and p.Gln113Glu) in 6 unrelated patients with mild to moderate, late onset, 
unexplained iron overload (Daher R, Gastroenterology 2016).
Methods
We recently updated our next generation sequencing (NGS)-based second level genetic test 
for the molecular diagnosis of non-HFE HH (Badar S, Am J Hematol 2016), by adding a 
number of novel potential candidate genes, including BMP6, to the panel of the 5 known HH 
genes. This test was applied to 38 patients evaluated at our tertiary referral centre for iron 
disorders, because of an unexplained iron overload phenotype.
Results
We found 3 heterozygous missense mutations in BMP6 gene in 4 patients with unexplained, 
late-onset, iron overload, from 3 different families. Their relevant clinical data are 
summarized into Table 1. Of note, 1 mutation (p.Leu96Pro) was the same recently described 
by Daher et al. and proven to be functional. The other two mutations (p.Glu112Gln, 
p.Arg257His) were novel, predicted damaging by bioinformatic tools, and both located in the 
pro-peptide domain, known to be crucial for appropriate BMP6 processing and secretion. 
They were further studied by in silico modelling, based on the available 3D structure of the 
TGFb, which also resulted to be consistent with their pathogenetic role.
Conclusions
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To the best of our knowledge, our results provide the first independent confirmation of the 
likely causal role of BMP6 mutations in late onset, moderate iron overload phenotype, 
unrelated to mutations in the established 5 HH genes.
Table 1.
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